caffeic acid has been researched along with Ischemic Attack, Transient in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcázar, A; Ayuso, MI; Chioua, M; Escobar-Peso, A; Gonzalo-Gobernado, R; Hadjipavlou-Litina, D; Infantes, L; Marco-Contelles, J; Martínez-Alonso, E; Montaner, J; Montoya, JJ | 1 |
| Ahn, JH; Cho, JH; Hwang, IK; Kim, IH; Kim, YM; Lee, JC; Lee, YL; Park, JH; Won, MH; Yan, BC; Yeun, GH; Yim, Y | 1 |
| Chu, LS; Fang, SH; Wang, ML; Wei, EQ; Ye, YL; Zhang, WP; Zhou, Y | 1 |
3 other study(ies) available for caffeic acid and Ischemic Attack, Transient
| Article | Year |
|---|---|
New Quinolylnitrones for Stroke Therapy: Antioxidant and Neuroprotective ( Z)- N- tert-Butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine Oxide as a New Lead-Compound for Ischemic Stroke Treatment.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Cells, Cultured; Free Radical Scavengers; Imines; Ischemic Attack, Transient; Lipid Peroxidation; Male; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Quinolines; Rats, Wistar; Reactive Oxygen Species | 2019 |
Neuroprotection of a novel synthetic caffeic acid-syringic acid hybrid compound against experimentally induced transient cerebral ischemic damage.
Topics: Animals; CA1 Region, Hippocampal; Caffeic Acids; Drug Evaluation, Preclinical; Gallic Acid; Gerbillinae; Ischemic Attack, Transient; Male; Neuroprotective Agents | 2013 |
Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats.
Topics: Animals; Antioxidants; Arachidonate 5-Lipoxygenase; Brain; Caffeic Acids; Cysteine; Infarction, Middle Cerebral Artery; Ischemic Attack, Transient; Leukotriene B4; Leukotrienes; Male; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2006 |